esophageal squamous cell carcinoma
Conditions
Interventions
None listed
Sponsors
Kyushu University
Fukuoka Dental College Hospital Biofermin Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients who are diagnosed with esophageal squamous cell carcinoma diagnosed at Kyushu University Hospital. (2)Patients who underwent neoadjuvant treatment and surgery.
Exclusion criteria
Exclusion criteria: Patients who were unsuitable for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Characteristics of the gut microbiome in esophageal cancer patients. Effect of chemoradiation therapy and surgery on gut microbiota in esophageal cancer patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Association with gut microbiome and surgical outcome, prognosis, clinical outcomes, blood test data, and gastrointestinal symptoms | — |
Countries
Japan
Contacts
Public ContactHirofumi Hasuda
Graduate School of Medical Sciences, Kyushu University Department of Surgery and Science
Outcome results
None listed